Leptomeningeal carcinomatosis: Presenting features and prognostic factors

Archives of Neurology

Volumn 53, Issue 7, 1996, Pages 626-632

  Balm, Michael ^a   Hammack, Julie ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CORTICOSTEROID;

ADULT; AGED; ARTICLE; CANCER CYTODIAGNOSIS; CANCER SURVIVAL; CARCINOMATOUS MENINGITIS; CENTRAL NERVOUS SYSTEM TUMOR; CLINICAL FEATURE; DEMENTIA; DIAGNOSTIC IMAGING; FEMALE; HEMIPARESIS; HUMAN; INTRACEREBROVENTRICULAR DRUG ADMINISTRATION; INTRATHECAL DRUG ADMINISTRATION; LEPTOMENINX; LEUKOENCEPHALOPATHY; MAJOR CLINICAL STUDY; MALE; MENINGOENCEPHALITIS; PAIN; PRIORITY JOURNAL; PROGNOSIS; PROTEIN CEREBROSPINAL FLUID LEVEL; SEIZURE; TUMOR DIAGNOSIS;

EID: 0029901665     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.1996.00550070064013     Document Type: Article

References (43)

1. Little JR, Dale AJD, Okazaki H. Meningeal carcinomatosis: clinical manifestations. Arch Neurol. 1974;30:138-143.
2. Eberth CJ. Zur Entwickelung des Epitheliomas (Cholesteatomas) der Pia und der Lunge. Virchows Arch. 1870;49:51-62.
3. Beerman WF. Meningeal carcinomatosis. JAMA. 1912;58:1437-1439.
4. Grossman SA, Moynihan TJ. Neoplastic meningitis. Neurol Clin. 1991;9:843-856.
5. Scanlon EF. The process of metastasis. Cancer. 1985;55:1163-1166.
6. Kokkoris CP. Leptomeningeal carcinomatosis: how does cancer reach the piaarachnoid? Cancer. 1983;51:154-160.
7. Yap HY, Yap BS, Tashima CK, DiStefano A, Blumenschein GR. Meningeal carcinomatosis in breast cancer. Cancer. 1978;42:283-286.
8. Rosen ST, Aisner J, Makuch RW, et al. Carcinomatous leptomeningitis in small cell lung cancer: a clinicopathologic review of the National Cancer Institute experience. Medicine. 1982;61:45-53.
9. Aroney RS, Dalley DN, Chun WK, Bell DR, Levi JA. Meningeal cancer in small cell carcinoma of the lung. Am J Med. 1981;71:26-32.
10. Amer MH, Al-Sarraf M, Baker LH, Viatkavicius VK. Malignant melanoma and central nervous system metastases: incidence, diagnosis, treatment and survival. Cancer. 1978;42:660-668.
11. Wasserstrom WR, Glass BJ, Posner JB. Diagnosis and treatment of leptomeningeal metastases from solid tumors: experience with 90 patients. Cancer. 1982; 49:759-772.
12. Theodore WH, Gendelman S. Meningeal carcinomatosis. Arch Neurol. 1981; 38:696-699.
13. Olsen ME, Chernik NL, Posner JB. Infiltration of the leptomeninges by systemic cancer: a clinical and pathologic study. Arch Neurol. 1974;30:122-137.
14. Sorenson SC, Eagan RT, Scott M. Meningeal carcinomatosis in patients with primary breast or lung cancer. Mayo Clin Proc. 1984;59:91-94.
15. Wasserstrom WR, Schwartz MK, Fleisher M, Posner JB. Cerebrospinal fluid biochemical tumor markers in central nervous system tumors: a review. Ann Clin Lab Sci. 1981;11:239-251.
16. Nagakawa H, Kubo S, Murasawa A, et al. Measurement of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors. J Neurooncol. 1992;12:111-120.
17. Malkin MG, Posner JB. Cerebrospinal fluid tumor markers for the diagnosis and management of leptomeningeal metastases. Eur J Cancer Clin Oncol. 1987; 23:1-4.
18. Van Zanten AP, Twijnstra A, Ongerboer de Visser BW, Van Heerde P, Hart AA, Nooyen WJ. Cerebrospinal fluid tumor markers in patients treated for meningeal malignancy. J Neurol Neurosurg Psychiatry. 1991;54:119-123.
19. Bach F, Bjerregaard B, Soletormos G, Bach FW, Horn T. Diagnostic value of cerebrospinal fluid cytology in comparison with tumor marker activity in CNS metastasis secondary to breast cancer. Cancer. 1993;72:2376-2382.
20. Schold SC, Wasserstrom WR, Fleisher M, Schwartz MK, Posner JB. Cerebrospinal fluid biochemical markers of central nervous system metastases. Ann Neurol. 1980;8:597-604.
21. Bach F, Bach FW, Pedersen AG, Larsen PM, Dombernowski P. Creatine kinase-BB in the cerebrospinal fluid as a marker of CNS metastasis and leptomeningeal carcinomatosis in patients with breast cancer, Eur J Cancer Clin Oncol. 1989;25:1703-1709.
22. Klee GS, Tallman RD, Goellner JR, Yanagihara T. Elevations of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis. Mayo Clin Proc. 1986;61:9-13.
23. Tallman RD, Kimbrough SM, O'Brien JF, Goellner JR, Yanagihara T. Assay for β-glucuronidase in CSF: usefulness for detection of neoplastic meningitis. Mayo Clin Proc. 1985;60:293-298.
24. Liaw CC, Ng KT, Huang JS, Wang CH, Kiu MC, Lai GM. Meningeal carcinomatosis from solid tumors: clinical analysis of 42 cases. J Formosan Med Assoc. 1992;91:299-303.
25. Boogerd W, Hart AAM, van der Sande JJ, Engelsman E. Meningeal carcinomatosis in breast cancer: prognostic factors and influence of treatment. Cancer. 1991;67:1685-1695.
26. Krol G, Sze G, Malkin M, Walker R. MR of cranial and spinal meningeal carcinomatosis: comparison with CT and myelography. AJR Am J Roentgenol. 1988;151:583-588.
27. Sze G, Soletsky S, Brunen R, Krol G. MR imaging of the cranial meninges with emphasis on contrast enhancement and meningeal carcinomatosis. AJNR Am J Neuroradiol. 1989;10:965-975.
28. Chamberlain MC, Sandy AD, Press GA. Leptomeningeal metastasis: a comparison of gadolinium-enhanced MR and contrast-enhanced CT of the brain. Neurology. 1990;40:435-438.
29. Freilich RJ, Krol G, DeAngelis LM. Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol. 1995;38: 51-57.
30. Grant R, Naylor B, Greengerg HS, Junck L. Clinical outcome in aggressively treated meningeal carcinomatosis. Arch Neurol. 1994;51:457-461.
31. Ongerboer de Visser BW, Somers R, Nooyen WH, van Heerde P, Hart AAM, McVie GM. Intraventricular methotrexate therapy of leptomeningeal metastasis from breast cancer. Neurology. 1983;33:1565-1573.
32. Nakagawa H, Kubo S, Murasawa A, et al. Diagnosis and treatment of patients with meningeal carcinomatosis. J Neurooncol. 1992;13:81-89.
33. Jayson GC, Howell A, Harris M, Morgenstern G, Chang J, Ryder WD. Carcinomatous meningitis in patients with breast cancer: an aggressive disease variant. Cancer. 1994;74:3135-3141.
34. Sigeal T, Lossos A, Pfeffer MR. Leptomeningeal metastasis: analysis of 31 patients with sustained off-therapy response following combined-modality therapy. Neurology. 1994;44:1463-1469.
35. Shapiro WR, Posner JB, Ishio Y, Chernik NL, Young DF. Treatment of meningeal neoplasms. Cancer Treat Rep. 1977;61:733-743.
36. Holleb AI, Fink DJ, Murphy GP. American Cancer Society Textbook of Clinical Oncology. Atlanta, Ga: The American Cancer Society Inc; 1994.
37. Rogers LR, Duchesnecu PM, Nunez C, et al. Comparison of cisternal and lumbar CSF examination in leptomeningeal metastasis. Neurology. 1992;42:1239-1241.
38. Coslett HB, Tejak L, Sutula TP. Meningeal carcinomatosis 21 years following bronchiolo-alveolar carcinoma: diagnosed by cisternal CSF examination. Cancer. 1982;49:173-176.
39. Grossman SA, Finkelstein DM, Ruckdeschel JC, Trump DL, Moynihan T, Ettinger DS. Randomized prospective comparison of intraventricular methotrexate and thiotepa in patients with previously untreated neoplastic meningitis. J Clin Oncol. 1993;11:561-569.
40. Hitchins RN, Bell DR, Woods RL, Levi JA. A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis. J Clin Oncol. 1987;5:1655-1662.
41. Sause WT, Crowley J, Eyre HJ, et al. Whole brain irradiation and intrathecal methotrexate in the treatment of solid tumor leptomeningeal metastasis: a Southwest Oncology Group Study. J Neurooncol. 1988;6:107-112.
42. Clamon G, Doebbeling B. Meningeal carcinomatosis from breast cancer: spinal cord versus brain involvement. Br Cancer Res Treat. 1987;9:213-217.
43. Schabet M, Kloeter I, Adam T, Heidemann E, Wietholter H. Diagnosis and treatment of meningeal carcinomatosis in ten patients with breast cancer, Eur Neurol. 1986;25:403-411.